VT-Tri(2)-G

N/A

Report date: 2025/01/26 16:21:37

Base Information

Drug NameVT-Tri(2)-G
Drug Alias NameVT-Tri-IIT-cell adoptive immunity therapy(ViGenCell)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVigencell Inc
China Registration ClassN/A

Develop Information

Active CompaniesVigencell Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A